Round of more than $6 million, led by Colle Capital Partners with support from Orlando Health Ventures, will fund completion of Sensydia's ongoing ACOUSTIC‑1 study for the Cardiac Performance System (CPS™) and preparation for commercial launch LOS ANGELES, Oct. 13, 2026 /PRNewswire/ --...